Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines

Shock

Volumn 5, Issue 3, 1996, Pages 167-183

  Battistini, Bruno ^a,b   Forget, Marie Annick ^a,c   Laight, David ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN;

ANAPHYLAXIS; ANIMAL; BLOOD; GENE EXPRESSION REGULATION; GENETICS; HEMORRHAGIC SHOCK; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPTIC SHOCK; SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANAPHYLAXIS; ANIMALS; CYTOKINES; ENDOTHELINS; GENE EXPRESSION REGULATION; HUMANS; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0030100121     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199603000-00002     Document Type: Review

References (181)

1. Baue AE: Multiple organ failure, multiple organ dysfunction syndrome, and, the systemic inflammatory response syndrome: Where do we stand? Shock 2:385-396, 1994.
2. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457-469, 1991.
3. Billiau A, Vandekerckhove F: Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 21:559-573, 1991.
4. Thiemermann C: The role of the L-arginine/nitric oxide pathway in circulatory shock. Adv Pharmacol 28:45-79, 1994.
5. Guc MO, Gray GA, Furman BL, Parratt JR: Endotoxin-induced impairment of vasodepressor responses in the pithed rat. Eur J Pharmacol 204:63-70, 1991.
6. Nathanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL: Selected treatment strategies for septic shock based on proposed mechanism of pathogenesis. Ann Intern Med 120:771-783, 1994.
7. Andersen BM, Solberg O: The endotoxin-liberating effect of antibiotics on meningococci in vitro. Acta Pathol Microbiol Scand 88:231-236, 1980.
8. Shenep JL, Morgan KA: Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 150:380-388, 1984.
9. Scannon PJ: A biotechnology perspective revisited: Now is sepsis out of vogue? Exp Opin Invest Drugs 3:893-894, 1994.
10. Schadt JC, Ludbrook J: Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol 260:H305-H318, 1991.
11. Bond RF, Johnson G: Vascular adrenergic interactions during hemorrhagic shock. Fed Proc 44:281-289, 1985.
12. Ayala J, Perrin MM, Meldrum DR, Ertel W, Chaudry IH: Hemorrhage induces the increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2:121-127, 1990.
13. Ayala J, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH: Differential alterations in plasma IL-6 and TNF which is not associated with elevated levels of endotoxin. Cytokine 2:170-174, 1991.
14. Klassen CD: Principles of Toxicology: The Pharmacological Basis of Therapeutics, vol. 3, 1990.
15. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
16. Saida K, Mitsui Y, Ishida N: A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family: Molecular cloning, expression, and biological activity. J Biol Chem 264:14613-14616, 1989.
17. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T: The human preproendothelin-1 gene: Complete nucleotide sequence and regulation of expression. J Biol Chem 264:14954-14959, 1989.
18. Nunez DJ, Brown MJ, Davenport AP, Neylon CB, Schofield JP, Wyse RK: Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 85:1537-1541, 1990.
19. Nakano J, Takizawa H, Ohtoshi T, et al: Endotoxin and pro-inflammatory cytokines stimulate endothelin-1 expression and release by airway epithelial cells. Clin Exp Allergy 24:330-336, 1994.
20. Ehrenreich H, Anderson RW, Fox CH, et al: Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172:1741-1748, 1990.
21. Lamas S, Michel T, Collins T, Brenner BM, Marsden PA: Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J Clin Invest 90:879-887, 1992.
22. Sugiura M, Inagami T, Kon V: Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 161:1220-1227, 1989.
23. Mahden PA, Brenner BM: Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 262:C854-C861, 1992.
24. Kanse SM, Takahashi K, Lam HC, et al: Cytokine stimulated endothelin release from endothelial cells. Life Sci 48:1379-1384, 1991.
25. Yoshizumi M, Kurihara H, Monta T, et al: Interleukin-1 increases the production of ET-1 by cultured endothelial cells. Biochem Biophys Res Commun 166:324-329, 1990.
26. Maemura K, Kurihara H, Morita T, Oh-hashi Y, Yazaki Y: Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 38:29-35, 1992.
27. Clozel M, Fischli W: Human cultured endothelial cells do secrete ET-1. J Cardiovasc Pharmacol 13:5229-3231, 1989.
28. Katabami T, Shimizu M, Okano K, et al: Intracellular signal transduction for interleukin-1 beta-induced endothelin production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 188:565-570, 1992.
29. Moldovan F: The effect of endotoxin on human umbilical vein endothelial cells in culture. FASEB J 122-.346A, 1994.
30. Sunnergren KP, Word RA, Sambrook JF, MacDonald PC, Casey ML: Expression and regulation of endothelin precursor mRNA in avascular human amnion. Mol Cell Endocrinol 68:R7-R14, 1990.
31. Ohlstein EH, Storer BL, Butcher JA, Debouck C, Feuerstein G: Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circ Res 69:832-841, 1991.
32. Nakamura T, Kasai K, Sekiguchi Y, et al: Elevation of plasma endothelin concentrations during endotoxin shock in dogs. Eur J Pharmacol 205: 277-282, 1991.
33. Endo T, Uchida Y, Matsumoto H, et al: Regulation of endothelin-1 synthesis in cultured guinea pig airway epithelial cells by various cytokines. Biochem Biophys Res Commun 186:1594-1599, 1992.
34. Ninomiya H, Uchida Y, Ishii Y, et al: Endotoxin stimulates endothelin release from cultured epithelial cells of guinea-pig trachea. Eur J Pharmacol 203:299-302, 1991.
35. Ohta K, Hirata Y, Imai T, et al: Cytokine-induced release of endothelin-1. from porcine renal epithelial cell line. Biochem Biophys Res Commun 169:578-584, 1990.
36. Kohan DE, Padilla E: Endothelin-1 production by rat inner medullary collecting duct: Effect of nitric oxide, cGMP, and immune cytokines. Am J Physiol 266:F291-F297, 1994.
37. Kohan DE: Production of ET-1 by rat mesangial cells: Regulation by tumor necrosis factor. J Lab Clin Med 119:477-484, 1992.
38. Zoja C, Orisio S, Perico N, et al: Constitutive expression of endolhelin gene in cultured human mesangial cells and its modulation by transforming growth factor-beta, thrombin, and thromboxane A2 analogue. Lab Invest 64:16-20, 1991.
39. Casey ML, Word RA, MacDonald PC: Endothelin-1 gene expression and regulation of endothelin mRNA and protein biosynthesis in avascular amnion: Potential source of amniotic fluid endothelin. J Biol Chem 266:5762-5768, 1991.
40. Mitchell MD, Lundin-Schiller S, Edwin SS: Endothelin production by amnion and its regulation by cytokines. Am J Obstet Gynecol 165:120-124, 1991.
41. Ehrenreich H, Anderson RW, Ogino Y, et al: Selective autoregulation of endothelins in primary astrocyte cultures: Endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol 3:135-141, 1991.
42. Yamashita J, Ogawa M, Nomura K, et al: Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res 53:464-467, 1993.
43. Economos K, MacDonald PC, Casey ML: Endothelin-1 gene expression and protein biosynthesis in human endometrium: Potential modulator of endometrial blood flow. J Clin Endocrinol Metab 74:14-19, 1992.
44. Inoue H, Wakisaka N, Tane N, et al: Endothelin-1 production by normal human culture keratinocytes and its regulation. Med Inflamm 3:433-437, 1994.
45. Tsuboi R, Sato C, Shi CM, Nakamura T, Sakurai T, Ogawa H: Endothelin-1 acts as an autocrine growth factor for normal human keratinocytes. J Cell Physiol 159:213-220, 1994.
46. Cunningham ME, Huribal M, McMillen MA: Endotoxin-stimulated monocytes produce endothelin. FASEB J 8:A214, 1994.
47. Zeballos GA, An S, Wu JM: ET-1 secretion by human fibroblasts in culture: Effects of cell density and IFN-β. Biochem Int 25:845-852, 1991.
48. Hemsen A, Modin A, Weitzberg E, Rudehill A, Nihlen C, Lundberg JM: Bosentan increases plasma levels of ET-1, but not big ET-1 in the pig endotoxin shock model. 4th International Conference on Endothelins, London, UK, 1995.
49. Opgenorth TJ, Wu-Wong JR, Shiosaki K: Endothelin-converting enzymes. FASEB J 6:2653-2659, 1992.
50. Battistini B, Botting B, Warner TD: Endothelins: A knockout in London. Trends Pharmacol Sci 16:217-222, 1995.
51. Matsumura Y, Ikegawa R, Suzuki Y, et al: Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: The relationship to ET-1 levels in the cerebrospinal fluid. Life Sci 49:841-848, 1991.
52. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S: N-ethylmaleimide differentiates ET converting activity by two types of metalloproteinases derived from vascular endothelial cells. Biochem Biophys Res Comm 178:531-538, 1991.
53. Hemsen A, Pernow J, Lundberg JM: Regional extraction of endothelins and conversion of big ET to ET-1 in the pig. Acta Physiol Scand 141:325-334, 1991.
54. Noguchi K, Fukuroda T, Ikeno Y, et al: Local formation and degradation of ET-1 in guinea-pig airway tissues. Biochem Biophys Res Comm 179:830-835, 1991.
55. Télémaque S, Lemaire D, Claing A, D'Orléans-Juste P: Phosphoramidon-sensitive effects of big endothelins in the perfused rabbit kidney. Hypertension 20:518-523, 1992.
56. Lehoux S, Plante GE, Sirois MG, Sirois P, D'Orléans-Juste P: Phosphoramidon blocks big ET-1 but not ET-1 enhancement of vascular permeability in the rat. Br J Pharmacol 107:996-1000, 1992.
57. Shinyama H, Uchida T, Kido H, et al: Phosphoramidon inhibits the conversion of intracistemally administered big ET-1 to ET-1. Biochem Biophys Res Commun 178:24-30, 1991.
58. Télémaque S, D'Orléans-Juste P: Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big ET-1, but not big ET-3 in the rat vas deferens. Naun Schmid Arch Pharmacol 344:505-507, 1991.
59. Naruse K, Naruse M, Watanabe Y, et al: Molecular form of immunoreactive endothelin in plasma and urine of normal subjects and patients with various disease states. J Cardiovasc Pharmacol 17:S506-S508, 1991.
60. Nambi P, Pullen M, Slivjak MJ, Ohlstein EH, Storer B, Smith EF: Endotoxin-mediated changes in plasma endothelin concentrations, renal endothelin receptor and renal function. Pharmacology 48:147-156, 1994.
61. Emori T, Hirata Y, Ohta K, Shichiri M, Shimokado K, Marumo F: Concommitant secretion of big endothelin and its C-terminal fragment from human and bovine endothelial cells. Biochem Biophys Res Commun 162:217-223, 1989.
62. Emori Y, Hirata Y, Ohta K, Shichiri M, Marumo F: Secretory mechanism of ir-ET in cultured bovine endothelial cells. Biochem Biophys Res Commun 160:93-100, 1989.
63. Xuan YT, Whorton AR, Shearer-Poor E, Boyd J, Watkins WD: Determination of immunoreactive-endothelin in medium from cultured endothelial cells and human plasma. Biochem Biophys Res Commun 164:326-332, 1989.
64. Yoshizumi M, Kurihara H, Sugiyama T, et al: Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 161:859-864, 1989.
65. Battistini B, D'Orléans-Juste P, Sirois P: Endothelins in physiopathology: Circulating plasma levels and presence in other biological fluids. Lab Invest 68:600-628, 1993.
66. Ehrenreich H, Burd PR, Rottem M, et al: Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol 4:147-156, 1992.
67. Sessa WC, Kaw S, Hecker M, Vane JR: The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 174:613-618, 1991.
68. Kaw S, Hecker M, Vane JR: The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 89:6886-6890, 1992.
69. Morita T, Kurihara H, Yoshizumi M, et al: Human polymorphonuclear leukocytes have dual effects on endothelin 1 : The induction of endothelin 1 mRNA expression in vascular endothelial cells and modification of the endothelin 1 molecule. Heart Vessels 8:1-6, 1993.
70. Boulanger C, Luscher TF: Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587-590, 1990.
71. Luscher TF: Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. Basic Res Cardiol 88:15-24, 1993.
72. Prins BA, Hu RM, Nazario B, Pedram A, Frank HJ, Weber MA, Levin ER: Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 269: 11938-11944, 1994.
73. Vemulapalli S, Chiu PJS, Griscti K, Brown A, Kurowski S, Sybertz EJ: Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur J Pharmacol 257:95-102, 1994.
74. Miyamori I, Takeda Y, Yoneda T, Iki K, Takeda R: Interleukin-2 enhances the release of endothelin-1 from the rat mesenteric artery. Life Sci 49:1295-1300, 1991.
75. Vemulapalli S, Chiu PJ, Rivelli M, Foster CJ, Sybertz EJ: Modulation of circulating endothelin levels in hypertension and endotoxemia in rats. J Cardiovasc Pharmacol 18:895-903, 1991.
76. Klemm P, Warner TD, Hohlfeld T, Corder R, Vane JR: Endothelin-1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci USA 92:2691-2695, 1995.
77. Huribal M, Kumar R, Cunningham M, Sumpio BE, McMillen MA: Endothelin causes production of interleukin 6 but not interleukin 1 by human monocytes. FASEB J 6:A1613, 1992.
78. Cunningham ME, Huribal M, McMillen MA: Endothelin-stimulated monocytes produce IL-1β, IL-8 and GM-CSF. Mol Biol Cell 4:451A, 1993.
79. Helset E, Sildnes T, Seljelid R, Konopski ZS: Endothelin-1 stimulates human monocytes in vitro to release TNF-α, IL-1β and IL-6. Med Inflamm 2:417-422, 1993.
80. Agui T, Xin X, Cai Y, Sakai T, Matsumoto K: Stimulation of interleukin-6 production by endothelin in rat bone marrow-derived stromal cells. Blood 84:2531-2538, 1994.
81. Stankova J, Turcotte S, Gingras D, D'Orléans-Juste P, Rola-Pleszczynski M: ET-1 induces interleukin 6 gene expression in human endothelial cells. 4th International Conference on Endothelins, London, UK, 1995.
82. Gomez-Garre D, Guerra M, Gonzalez E, et al: Aggregation of human polymorphonuclear leukocytes by endothelin: Role of platelet-activating factor. Eur J Pharmacol 224:167-172, 1992.
83. 4. J Surg Res 54:331-335, 1993.
84. Ishida K, Takeshige K, Minakami S: Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl- phenylalanine. Biochem Biophys Res Commun 173:496-500, 1990.
85. Huribal M, Kumar R, Cunningham ME, Sumpio BE, McMillen MA: Endothelin-stimulated monocyte supernatants enhance neutrophil superoxide production. Shock 1:184-187, 1994.
86. Bath PM, Mayston SA, Martin JF: Endothelin and PDGF do not stimulate peripheral blood monocyte chemotaxis, adhesion to endothelium, and superoxide production. Exp Cell Res 187:339-342, 1990.
87. Achmad TH, Rao GS: Chemotaxis of human blood monocytes toward endothelin 1 and the influence of calcium channel blockers. Biochem Biophys Res Commun 189:994-1000, 1992.
88. Millul V, Lagente V, Gillardeaux O, et al: Activation of guinea-pig alveolar macrophages by endothelin-1. J Cardiovasc Pharmacol 17: S233-S235, 1991.
89. 2 production in human alveolar macrophages. Am J Physiol 261:L478-L484, 1991.
90. Yamamoto C, Kaji T, Sakamoto M, Kozuka H: Modulation by endothelin-1 of tissue plasminogen activator and plasmogen activator inhibitor-1 release from culture human vascular endothelial cells: Interaction of endothelin-1 with cytokines. Biol Pharm Bull 16:714-715, 1993.
91. Shiba R, Yanagisawa M, Miyauchi T, Ishii Y, Kimura S, Uchiyama Y, Masaki T, Goto K: Elimination of intravenously injected endothelin-1 from the circulation of rat. J Cardiovasc Pharmacol 13:S98-S101, 1989.
92. Anggard E, Galton S, Rae G, et al: The fate of radioiodinated ET-1 and ET-3 in the rat. J Cardiovasc Pharmacol 13:S46-S49, 1989.
93. De Nucci G, Thomas R, D'Orleans-Juste P, et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Nat Acad Sci USA 85:9797-9800, 1988.
94. Sirvio ML, Metsarinne K, Saijonmaa O, Fyhrquist F: Tissue distribution and half-life of 1251-endothelin in the rat: Importance of pulmonary clearance. Biochem Biophys Res Commun 167:1191-1195, 1990.
95. Kohno M, Murakawa K, Yasunari K, Yokokawa K, Horio T, Kurihara N, Takeda T: Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats. Metabolism 38:712-713, 1989.
96. Pernow J, Hemsen A, Lundberg JM: Tissue-specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun 161:647-653, 1989.
97. Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB: The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 265:14150-14155, 1990.
98. Edano T, Arai K, Ohshima T, et al: Purification and characterization of endothelin-1 degradation activity from porcine kidney. Biol Pharmacol Bull 17:379-582, 1994.
99. Janas J, Sitkiewic D, Pulawska MF, Waraawin K, Janas RM: Characterization of a novel, high-moleculr weight, acidic, endothelin-1-inactivating metalloendopeptidase from the rat kidney. J Hypertens 12:1155-1162, 1994.
100. Druml W, Steltzer H, Waldgausl W, et al: Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 148:1169-1173, 1993.
101. Weitzberg E, Lundberg JM, Rudehill A: Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33:222-227, 1991.
102. Takakuwa T, Endo S, Nakae H, et al: Plasma levels of TNF-α, endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol 84:261-269, 1994.
103. Moldovan F, Boudaoud S, Jacob L, et al: Significant differences between arterial and venous ET-LI in human plasma. Clin Chem 37:2012, 1991.
104. Mitaka C, Hirata Y, Makita K, Nagura T, Tsunoda Y, Amaha K: Endothelin-1 and atrial natriuretic peptide in septic shock. Am Heart J 126:466-468, 1993.
105. Pittet JF, Morel DR, Hemsen A, et al: Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213:261-264, 1991.
106. Hirata Y, Mitaka C, Emori T, Amaha K, Marumo F: Plasma endothelins in sepsis syndrome. J Am Med Assoc 270:2182, 1993.
107. Voerman HJ, Stehouwer CD, van-Kamp GJ, Strack-van-Schijndel RJ, Groeneveld AB, Thijs LG: Plasma endothelin levels are increased during septic shock. Crit Care Med 20:1097-1101, 1992.
108. Lundberg JM, Ahlborg G, Hemsen A, et al: Evidence for release of endothelin-1 in pigs and humans. J Cardiovasc Pharmacol 17:S350-S353, 1991.
109. Pemow J, Hemsen A, Hallen A, Lundberg JM: Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig. Acta Physiol Scand 140: 311-322, 1990.
110. Redl H, Schlag G, Bahrami S, et al: Big endothelin release in baboon bacteremia is partially TNF dependent. J Lab Clin Med 124:796-801, 1994.
111. Sakurai T, Yanagisawa M, Masaki T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-108, 1992.
112. Karne S, Jayawickreme CK, Lerner MR: Cloning and characterization of an ET-3-specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem 268:19126-19133, 1993.
113. Kumar C, Mwangi V, Nuthulanganti P, et al: Cloning and characterization of a novel endothelin receptor from Xenopus heart. J Biol Chem 269:13414-13420, 1994.
114. Nambi P, Pullen M, Kumar C: Identification of a novel endothelin receptor in Xenopus laevis liver. Neuropeptides 26:181-185, 1994.
115. Warner TD, Battistini B, Doherty AM, Corder R: Endothelin receptor antagonists: Actions and rationale for their development. Biochem Pharmacol 48:625-635, 1994.
116. Miller RC, Pelton JT, Huggins JP: Endothelins: From receptors to medicine. Trends Pharmacol Sci 14:54-60, 1993.
117. Takuwa Y, Kasuya Y, Takuwa N, et al: Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. J Clin Invest 85:653-658, 1990.
118. Eguchi S, Kozuka M, Hirose S, et al: Identification of G protein-coupled endothelin receptors in cultured bovine endothelial cells. Biochem Biophys Res Commun 174:1343-1346, 1991.
119. Aramori I, Nakanishi S: Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 267:12468-12474, 1992.
120. Eguchi S, Hirata Y, Imai T, Marumo F: Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature. Endocrinology 132:524-529, 1993.
121. Hyslop S, De-Nucci G: Vasoactive mediators released by endothelins. Pharmacol Res 26:223-242, 1992.
122. Rubanyi GM, Polokoff MA: Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415, 1994.
123. Fleming I, Gray GA, Jolou-Schaeffer G, Parrat J, Stoclet JC: Incubation with endotoxin activates the L-arginine pathway in vascular smooth tissue. Biochem Biophys Res Commun 171:562-568, 1990.
124. Smith REA, Palmer RMJ, Moncada S: Coronary vasodilation induced by endotoxin in the rabbit isolated perfused heart is nitric oxide-dependent and inhibited by dexamethasone. Br J Pharmacol 104:5-6, 1991.
125. Auguet M, Delaflotte S, Chabrier PE, Braquet P: Loss of contractile stability induced by phenylephrine and endothelin in the aorta of rats treated with endotoxin. Arch Mal Coeur Vaiss 83:1187-1190, 1990.
126. Mitchell JA, Kohlhaas KL, Sorrentino R, Warner TD, Murad F, Vane JR: Induction by endotoxin of nitric oxide synthase in the rat mesentery: Lack of effect on action of vasoconstrictors. Br J Pharmacol 109:265-270, 1993.
127. Guc MO, Furman BL, Parratt JR: Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 101:913-919, 1990.
128. Egger D, Geuenich S, Denzlinger C, et al: IL-4 renders mast cells functionally responsive to endothelin-1. J Immunol 154:1830-1837, 1995.
129. Naruse M, Naruse K, Kurimoto F, et al: Radioimmunoassay for endothelin and ir-ET in culture medium of bovine endothelial cells. Biochem Biophys Res Commun 160:662-668, 1989.
130. Sawamura T, Kimura S, Shinmi O, Sugita Y, Yanagisawa M, Masaki T: Analysis of ET related peptides in culture supernatant of porcine aortic endothelial cells: Evidence for biosynthetic pathway of ET-1. Biochem Biophys Res Commun 162:1287-1294, 1989.
131. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M: Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 115:199-204, 1994.
132. Kitajima T, Tani K, Kubota Y, et al: Role of endogenous endothelin in gastric mucosal injury induced by endotoxin shock in rats. Gastroenterol A107, 1994.
133. Pollock DM, Divish BJ, Opgenorth TJ: Stimulation of endogenous endothelin release in the anesthetized rat. J Cardiovasc Pharmacol 22: S295-S298, 1993.
134. Tsukada K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Nagamachi Y: increased plasma endothelin-1 concentrations in E. coli septic peritonitis rats with diabetes mellitus. Exp Clin Endocrinol 101:315-318, 1993.
135. Lerman A, Burnett JC: Exogenous endothelin-1 reverses endotoxin mediated hypotension. 3rd International Conference on Endothelins, Houston, TX, 1993.
136. Weitzberg E, Rudehill A, Lundberg JM: Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 233:85-94, 1993.
137. Pernow J, Hemsen A, Lundberg JM: Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol Scand 137:317-318, 1989.
138. Myhre U, Pettersen JT, Risoe C, Giercksky KE: Endothelin-1 and endotoxemia. J Cardiovasc Pharmacol 22:5291-5294, 1993.
139. Han JJ, Windsor A, Drenning DH, et al: Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock. Shock 1:342-346, 1994.
140. Morel DR, Pittet JF, Gunning K, Hemsen A, Lacroix JS, Lundberg JM: Time course of plasma and pulmonary lymph endothelin-like immunoreactivity during sustained endotoxemia in chronically instrumented sheep. Clin Sci 81:357-365, 1991.
141. Morel DR, Lacroix JS, Hemsen A, Steinig DA, Pittet JF, Lundberg JM: Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 167:427-428, 1989.
142. Tsukada K, Katoh H, Shiojima M, Takenoshita S, Nagamachi Y: Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis. APMIS 101:97-100, 1993.
143. Takakuwa T, Endo S, Nakae H, et al: Relationship between plasma levels of type II phospholipase A2, PAF-acethylhydrolase, leukotriene B4, complements, endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol 84:271-281, 1994.
144. Lundblad R, Ekstrom P, Giercksky KE: E5 monoclonal anti-endotoxin antibody improves survival and reduces LPS, TNF, lactate and endothelin in lethal rat abdominal sepsis. In Biol Resp Modifiers, San Diego CA: 2nd International Congress on Biological Response Modifiers 1993 (abstract).
145. Mozes T, Zijlstra FJ, Heiligers JPC, et al: Sequential release of tumour necrosis factor, platelet-activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: Protective effects of indomethacin. Br J Pharmacol 104:691-699, 1991.
146. Weitzberg E: Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation. Acta Physiol Scand Suppl 61:1-72, 1993.
147. Noda H, Noshima S, Nakazawa H, et al: Left ventricular dysfunction and acute lung injury induced by continuous administration of endotoxin in sheep. Shock 1:1-8, 1994.
148. Redl H, Schlag G, Schiesser A, Davies J: Tumor necrosis factor is a mediator of phospholipase release during bacteremia in baboons. Am J Physiol 264:H2119-H2123, 1993.
149. Fisher CJ, Opal SM, Dhainaut JF, et al: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokines levels in patients with sepsis: The CB0006 sepsis syndrome study group. Crit Care Med 21: 318-327, 1993.
150. Itoh K, Goseki N, Endo M, Hirata Y, Marumo F: Intraoperative hemorrhage affects endothelin-1 concentrations. Am J Gastroenterol 86:118-119, 1991.
151. Zimmerman RS, Maymind M, Barbee RW: Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension 23:205-210, 1994.
152. Leskinen H, Ruskoaho H, Huttunen P, Leppaluoto J, Vuolteenaho O: Hemorrhage effects on plasma ANP, NH2-terminal pro-ANP, and pressor hormones in anesthetized and conscious rats. Am J Physiol 266: R1933-R1943, 1994.
153. Michida T, Kawano S, Masuda E, et al: Role of endothelin 1 in hemorrhagic shock-induced gastric mucosal injury in rats. Gastroenterology 106:988-993, 1994.
154. Knuepfer MM, O'Brien D, Hoang D, Song C: Central sympathetic control of spinal endothelin release in the rat. Eur J Pharmacol 259:305-308, 1994.
155. Filep JG, Télémaque S, Battistini B, Sirois P, D'Orléans-Juste P: Increased plasma levels of endothelin during anaphylactic shock in the guinea-pig. Eyr J Pharmacol 239:231-236, 1993.
156. Schlichting E, Aspelin T, Grotmol T, Lyberg T: Endothelin and hemodynamic responses to superior mesenteric occlusion shock and hemorrhagic shock in pigs. Shock 3:109-115, 1995.
157. Vemulapalli S, Chiu PJS, Rivelli M, Cedeno K, Coleman W, Sybertz EJ: Tumor necrosis factor and hemorrhage produce elevation of plasma endothelin in rats. FASEB J 4:A456, 1990.
158. Horio T, Kohno M, Yokokawa K, et al: Effect of hypoxia on plasma ir-ET-1 concentration in anesthetized rats. Metabolism 40:999-1001, 1991.
159. Shirakami G, Nakao K, Saito Y, et al: Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci 48:969-976, 1991.
160. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K: Circulating endothelin-1 concentrations in acute respiratory failure. Chest 104:476-480, 1993.
161. Simmet T, Pritze S, Thelen KI, Peskar BA: Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats. Eur J Pharmacol 211:319-322, 1992.
162. ritze S, Peskar BA, Simmet T: Release of eicosanoids and endothelin in an experimental model of adult respiratory distress syndrome. Agents Actions 37:41-46, 1992.
163. Ishibashi M, Saito K, Watanobe K, Uesugi S, Furue H, Yamaji T: Plasma endothelin-1 levels in patients with disseminated intravascular coagulation. N Engl J Med 324:1516-1517, 1991.
164. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF: Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 110:169-173, 1992.
165. Morise Z, Takeuchi Y, Takeda R, Karayalcin U, Yachie A, Miyawaki T: Increased plasma endothelin levels in Kawasaki disease: A possible marker for Kawasaki disease. Angiology 44:719-723, 1993.
166. Lerman A, Hidelbrand FL, Aarhus LL, Bumett JC: Endothelin has biological actions at physiological concentrations. Circ 83:1808-1814, 1991.
167. Donckier JE, Hanet C, Berbinschi A, et al: Cardiovascular and endocrine effects of ET-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circ 84:2476-2484, 1991.
168. Ruetten H, Battistini B, Thiemermann C, Vane JR: Endothelin receptor blockade augments hypotension, organ injury and mortality in endotoxic shock in the rat. Circulation 92:1-429.
169. Weitzberg E, Rudehill A, Modin A, Hemsen A, Wanecek M, Lundberg JM: Bosentan improves cardiopulmonary performance in porcine endotoxin shock. 4th International Conference on Endothelins, London, UK, 1995.
170. Thabes JS, Lefferts PL, Lu WX, Snapper JR: An endothelin-A receptor antagonist (BMS 182874) attenuates endotoxin-induced pulmonary hypertension in sheep. 9th International Conference on Prostaglandins, Florence, Italy, 1994.
171. Badr KF: Sepsis-associated renal vasoconstriction: Potential targets for future therapy. Am J Kidney Dis 20:207-213, 1992.
172. Wellings R, Corder R, Vane JR: Endotoxin induces renal vasoconstriction in the anaesthetized rat: Effect of the non-selective endothelin receptor antagonist, PD 145065. Br J Pharmacol 112:496P, 1994.
173. Wilson MA, Steeb GD, Garrison RN: Endothelins mediate intestinal hypoperfusion during bacteremia. J Surg Res 55:168-175, 1993.
174. Ozsan K, Turker RK, Ercan ZS: Possible involvement of endothelin peptides and L-arginine-nitric oxide pathway on the effect of endotoxin in the rabbit isolated perfused kidney. Med Inflamm 3:211-214, 1994.
175. Etienne A, Pannetier MC, Soulard C, Braquet P: Effects of endothelin on the lethality induced by platelet-activating factor or endotoxin in the mouse. Circ Shock 32:77-81, 1990.
176. Warner TD, De Nucci G, Vane JR: Comparison of the survival of endothelium-derived relaxing factor and nitric oxide within the isolated perfused mesenteric arterial bed of the rat. Br J Pharmacol 97:777-782, 1989.
177. Stewart DJ, Cernacek P, Costello KB, Rouleau JL: Elevated ET-1 in heart failure and loss of normal response to postural change. Circ 85:510-517, 1992.
178. Lloyd MA, Sandberg SM, Miller WL, Edwards BS: Activation of plasma renin activity and aldosterone by endogenous endothelin during hypotensive hemorrhage. Am J Hypertens 4:4A, 1991.
179. Filep JG, Foldes-Filep E, Rousseau A, Fournier A, Sirois P, Yano M: Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol 219:343-344, 1992.
180. Rosenberg SA, Lotze MT, Yang JC, Topalian SL, Chang AE: Prospective
181. Ochoa JB, Curtis B, Peitzman AB, et al: Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes. J Natl Cancer Inst 84:864-867, 1992.